Neurodegenerative diseases are generally considered to be non-inflammatory, unlike autoimmune diseases such as multiple sclerosis, which are neurodegenerative diseases that are inflammatory in nature (Trapp et al., 1999a, b; Hohlfeld and Wiendl, 2001; Groom et al., 2003). Nevertheless, most neurodegenerative diseases are accompanied by a local inflammatory response, widely assumed to be unfavorable for CNS recovery (Kurosinski and Gotz, 2002; Jellinger, 2003; Popovich and Jones, 2003). Moreover, the progressive degeneration seen in such diseases is often mediated by compounds and processes that are secondary to the primary risk, e.g., misfolding and aggregation of self-proteins (Shastry, 2003). These primary and secondary risk factors represent a continuous threat to any viable neurons embedded in a chronically diseased tissue; they induce abnormalities in cells in their vicinity, thereby contributing to the chaos rather than helping to resolve it.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kipnis, J., Schwartz, M. (2008). Protective and Regenerative Autoimmunity in CNS Injury. In: Gendelman, H.E., Ikezu, T. (eds) Neuroimmune Pharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72573-4_45
Download citation
DOI: https://doi.org/10.1007/978-0-387-72573-4_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-72572-7
Online ISBN: 978-0-387-72573-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)